Zeria Pharmaceutical Co (TSE:4559) Net Income From Continuing Operations : 円8,414 Mil (TTM As of Sep. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Zeria Pharmaceutical Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Zeria Pharmaceutical Co's net income from continuing operations for the three months ended in Sep. 2024 was 円1,887 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was 円8,414 Mil.

Zeria Pharmaceutical Co Net Income From Continuing Operations Historical Data

The historical data trend for Zeria Pharmaceutical Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeria Pharmaceutical Co Net Income From Continuing Operations Chart

Zeria Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

3,920.28

3,956.55

5,721.76

7,272.70

9,508.39

Zeria Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Income From Continuing Operations	Get a 7-Day Free Trial															2,494.08	3,030.01	-742.67	4,239.00	1,887.35

Zeria Pharmaceutical Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円8,414 Mil.

Zeria Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zeria Pharmaceutical Co Ltd (TSE:4559) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351

Website

http://www.zeria.co.jp

Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.

Zeria Pharmaceutical Co Headlines

No Headlines